Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 66 pseudogene (ENSG00000258375) is a predicted human pseudogene related to the protein-coding transmembrane protein 66 gene. As a pseudogene, it results from historical gene duplication or mutation events and is not believed to encode a functional protein. Pseudogenes may sometimes give rise to non-coding RNAs or participate in gene expression regulation, but no such roles are documented for this locus. It is not considered a therapeutic drug target and carries no current relevance for disease association, interaction profiles, or biomarker use[1][3][4][7]. The gene name reflects its similarity to the TMEM66 protein, but loss-of-function changes render it inactive. If you need annotation for a functionally active transmembrane protein or verified receptor, please specify a protein-coding gene (not a pseudogene).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 66 pseudogene.